BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:[ SNSF - European Joint Programme on Rare Diseases - Call for join
 t research projects ]
DTSTART;VALUE=DATE:20220216
DTSTAMP:20260916T061410Z
UID:9477851ed00a286e84f7a42e5947847a6bc6fe16161245018de69996
CATEGORIES:Call for proposal
DESCRIPTION:The European Joint Programme on Rare Diseases (EJP-RD) is laun
 ching a new joint transnational call for research projects on “Developme
 nt of new analytic tools and pathways to accelerate diagnosis and facilita
 te diagnostic monitoring of rare diseases”.\n\nA number of national and 
 regional funding organisations participate in the EJP RD Joint Transnation
 al Call (JTC) 2022 and will fund multilateral research projects on rare di
 seases under the EJP-COFUND action. For Switzerland\, the SNSF is the Fund
 ing Agency.\n\nProjects shall focus on a group of rare diseases or a singl
 e rare disease following the European definition i.e.\, a disease affectin
 g not more than five in 10.000 persons in the European Community\, EC asso
 ciated states\, Australia and Canada.\nResearch proposals should cover at 
 least one of the following areas\n\n	Phenotype-driven diagnosis: integrati
 on across different ontologies\, integration of shared pathways\, digital 
 phenotyping\, development of artificial intelligence approaches/applicatio
 ns to extract health related data in aid of diagnosis\;\n	Prognostic marke
 rs/biomarkers investigations for early diagnosis and monitoring\;\n	Method
 ologies for solving cases that are currently difficult to analyze due to d
 ifferent underlying mechanisms (e.g. mosaicism\, genomic (non-coding) alte
 rations\, gene regulation\, complex inheritance)\, including new genomics 
 / functional genomics technologies\, multi-omics\, mathematics\, biostatis
 tics\, bioinformatics and artificial intelligence approaches\;\n	Functiona
 l strategies to globally stratify variants of unknown significance (VUS) f
 or clinical use\; setting up of (in vitro) systems to distinguish between 
 VUS and pathogenic variants (e.g. confirming disruption of splicing for de
 ep intronic variants\, loss of protein function\, and gain of toxic protei
 n function)\;\n	Development of pathway models to enable diagnosis\, especi
 ally for newly discovered diseases that may share underlying molecular mec
 hanisms with already known diseases.\n\n\nWho can apply: \n\n\n	Consortia 
 must involve 4-6 eligible PIs from at least 4 different participating coun
 tries. No more than two eligible partners from the same country can be pre
 sent in each consortium.\n	All partners in a consortium are supported by t
 he research funding organisations of their respective countries or regions
  and must follow the country-specific guidelines included in the call docu
 ment (see p.69).\n	Applicants from Switzerland must be eligible for SNSF p
 roject funding. Please have a look at the EPFL Toolkit for Project Funding
 . The SNSF invites you to contact them (tobias.braun@snf.ch) to verify you
 r eligibility\, unless you hold a Project Funding grant already.\n\n\nFund
 ing: The SNSF has allocated 1 Mio Swiss Francs for 3-4 partners.\n\nDurati
 on: max. 3 years\n\nDeadlines:\n\n\n	16 February 2022\, at 2 pm (CET): pre
 -proposal submission deadline\n	End April 2022: Invitation to submit a ful
 l proposal\n	15 June 2022: full proposal submission deadline\n	December 20
 22: notification of funding decision\n\n\nSubmission Process: The proposal
 s (pre-proposal and full proposal) have to be submitted to the EJP-RD subm
 ission system and the mySNF platform (please select "ERA-NET + EJP: Pre-pr
 oposal" for pre-proposals).\n\nFor further information\, please have a loo
 k at the call webpage\, the call text\, the call guidelines and the pre-pr
 oposal form.\n 
LOCATION:
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR